(Q63214366)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699948%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

[Treatment of Behçet's disease yesterday and today] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699948%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699948%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

C M E Deuter

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699948%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

M Zierhut

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699948%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

D Doycheva

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699948%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699948%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

number of pages

7

1 reference

inferred from page(s)

published in

Ophthalmologe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699948%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699948%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699948%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

568-574

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699948%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00347-011-2504-9

5 February 2020

exact match

0 references

cites work

The use of interferon alpha in Behçet disease: review of the literature

1 reference

12 December 2020

Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease

1 reference

12 December 2020

Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study

1 reference

12 December 2020

EULAR recommendations for the management of Behçet disease

1 reference

12 December 2020

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

1 reference

12 December 2020

Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.

1 reference

12 December 2020

Treatment of retinal vasculitis in Behçet's disease with rituximab

1 reference

12 December 2020

Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease

1 reference

12 December 2020

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 reference

12 December 2020

Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy.

1 reference

12 December 2020

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

1 reference

12 December 2020

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

1 reference

12 December 2020

CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.

1 reference

12 December 2020

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

1 reference

12 December 2020

Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease

1 reference

12 December 2020

Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments

1 reference

12 December 2020

A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease

1 reference

12 December 2020

Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome

1 reference

12 December 2020

Behçet's disease: ocular effects and treatment

1 reference

12 December 2020

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

1 reference

12 December 2020

Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial

1 reference

12 December 2020

A controlled trial of azathioprine in Behçet's syndrome

1 reference

12 December 2020

Medical management of Behçet's syndrome

1 reference

12 December 2020